Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Loncar Cancer Immunotherapy ETF | CNCR | Sep 20, 2024 | 15.69 | -0.51 |
Long-Term Bond Index ETF Vanguard | BLV | Sep 20, 2024 | 75.64 | -0.08 |
Long-Term Corp Bond Idx ETF Vanguard | VCLT | Sep 20, 2024 | 81.70 | +0.05 |
Long-Term Govt Bond Idx ETF Vanguard | VGLT | Sep 20, 2024 | 61.96 | -0.24 |
Longboard Pharmaceuticals | LBPH | Sep 20, 2024 | 33.89 | +1.47 |
Longeveron | LGVN | Sep 20, 2024 | 2.04 | -0.97 |
Loop Industries | LOOP | Sep 20, 2024 | 1.61 | +4.55 |
Lottery.com | LTRY | Sep 20, 2024 | 0.52 | -18.44 |
Lotus Technology | LOT | Sep 20, 2024 | 5.19 | +1.17 |
Louisiana-Pacific | LPX | Sep 20, 2024 | 105.55 | +1.35 |
Lovesac | LOVE | Sep 20, 2024 | 26.12 | -5.43 |
Lowes | LOW | Sep 20, 2024 | 260.14 | -0.33 |
LPL Financial | LPLA | Sep 20, 2024 | 215.52 | -2.40 |
LQR House | LQR | Sep 20, 2024 | 0.61 | -2.45 |
LSB Industries | LXU | Sep 20, 2024 | 7.69 | -4.00 |
LSI Industries | LYTS | Sep 20, 2024 | 16.04 | +0.19 |
Ltc Properties | LTC | Sep 20, 2024 | 36.00 | -1.37 |
Lucas GC | LGCL | Sep 20, 2024 | 1.31 | +9.17 |
Lucid Diagnostics | LUCD | Sep 20, 2024 | 0.82 | +0.76 |
Lucid Group | LCID | Sep 20, 2024 | 3.49 | -3.32 |
Lufax ADR | LU | Sep 20, 2024 | 2.27 | -0.87 |
Lululemon Athletica | LULU | Sep 20, 2024 | 262.61 | -3.01 |
Lulus Fashion Lounge | LVLU | Sep 20, 2024 | 1.55 | +6.90 |
Lumen Technologies | LUMN | Sep 20, 2024 | 6.66 | -0.60 |
Lument Finance Trust | LFT | Sep 20, 2024 | 2.65 | +2.32 |
Lument Finance Trust A Pref | LFT-A | Sep 20, 2024 | 22.96 | +4.36 |
Lumentum | LITE | Sep 20, 2024 | 61.35 | +0.34 |
Luminar Technologies A | LAZR | Sep 20, 2024 | 0.84 | +5.73 |
Lumos Pharma | LUMO | Sep 20, 2024 | 3.93 | +0.26 |
Luna Innovations | LUNA | Sep 20, 2024 | 2.21 | -2.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.